CTOs on the Move

Prognosis Health Information Services

www.prognosishis.com

 
Prognosis Health Information Systems (PROGNOSIS) is the progeny of an eight year old hospital business software vendor and a thirty-five year old medical records service and software provider which have provided products and services to hospitals across America.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Animale Parfums

Animale Parfums is a Hollywood, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Jupiter Medical Center

Jupiter Medical Center, your not for profit community hospital. As the area`s #1 Preferred Hospital, Jupiter Medical Center delivers compassionate care, at the forefront of clinical innovation. World-class care is close at hand with our team of leading healthcare professionals, our specialized centers and the latest technologies for diagnosis and treatment.

General Systems Designs Inc

General Systems Designs Inc is a Cedar Rapids, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Accord BioPharma

Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.

Sanomedics

Sanomedics International Holdings, Inc. (SIMH) manufactures and distributes innovative professional medical, as well as, home health diagnostic devices and products.